Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease

Am J Cardiol. 2000 Jul 15;86(2):250-2. doi: 10.1016/s0002-9149(00)00872-9.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anticholesteremic Agents / therapeutic use*
  • Atorvastatin
  • Cholesterol, LDL / blood
  • Coronary Disease / blood
  • Coronary Disease / drug therapy*
  • Female
  • Heptanoic Acids / therapeutic use*
  • Humans
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / drug therapy*
  • Male
  • Middle Aged
  • Pyrroles / therapeutic use*
  • Randomized Controlled Trials as Topic

Substances

  • Anticholesteremic Agents
  • Cholesterol, LDL
  • Heptanoic Acids
  • Pyrroles
  • Atorvastatin